Third Rock Ventures, a Boston venture capital firm targeting innovative life science start-ups, said today that it has raised more than $500 million for a new investment fund.
Business - Boston.com, Boston Globe: Business
Mon, 03/25/2013 - 10:12am
Third Rock Ventures, a Boston venture capital firm targeting innovative life science start-ups, said today that it has raised more than $500 million for a new investment fund.